(Q39188518)

9 September 2017

Monotherapy with sodium artesunate for uncomplicated falciparum malaria in Thailand: a comparison of 5- and 7-day regimens (English)

1 reference

9 September 2017

0 references

0 references

Plasmodium falciparum

0 references

malaria

0 references

author

Sornchai Looareesuwan

1

object named as

Looareesuwan S

1 reference

9 September 2017

2

Wilairatana P

1 reference

9 September 2017

Vanijanonta S

3

1 reference

9 September 2017

Pitisuttithum P

4

1 reference

9 September 2017

Ratanapong Y

5

1 reference

9 September 2017

Andrial M

6

1 reference

9 September 2017

1 September 1997

1 reference

9 September 2017

1 reference

9 September 2017

67

1 reference

9 September 2017

3

1 reference

9 September 2017

197-205

1 reference

Neurotoxicity in animals due to arteether and artemether.

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900063-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900063-6

Single dose artemisinin-mefloquine treatment for acute uncomplicated falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900063-6

Qinghaosu (artemisinin): an antimalarial drug from China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900063-6

Clinical trials of artemisinin and its derivatives in the treatment of malaria in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900063-6

High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900063-6

Efficacy of quinine-tetracycline for acute uncomplicated falciparum malaria in Thailand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900063-6

Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900063-6

Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900063-6

Randomised trial of mefloquine-tetracycline and quinine-tetracycline for acute uncomplicated falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900063-6

Mefloquine-resistant falciparum malaria on the Thai-Burmese border

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900063-6

High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900063-6

Randomized trial of mefloquine alone and artesunate followed by mefloquine for the treatment of acute uncomplicated falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900063-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Comparative clinical trial of artesunate followed by mefloquine in the treatment of acute uncomplicated falciparum malaria: two- and three-day regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900063-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0001-706X(97)00063-6

1 reference

9 September 2017

1 reference